Biotechnology, Consumer Staples, Food Distribution, Health Care, mid cap, Rate Cuts, stock selection, value
The fund outperformed through strong stock selection in healthcare and consumer staples, aided by biotech names like Argenx and Alnylam. Managers added positions in Bio-Techne and QXO to capture growth in diagnostics and industrial automation. They remain constructive on mid caps as rate cuts and improving sentiment support selective growth investing.
This report provides a detailed summary of investor holdings for a
specified stock ticker, highlighting key metrics such as fund
name, total assets under management (AUM), invested value,
portfolio weight, and shares owned. It also tracks changes in
share ownership during the last quarter, including the percentage
of shares bought or sold and the percentage of outstanding shares
owned. The data is generated using an API that processes investor
holdings and calculates these values for each fund. This report
helps investors and analysts monitor the stock positions of major
funds, identify investment trends, and assess the influence of
large investors on individual stocks.
